Hepatitis C
- PMID: 10938509
- DOI: 10.1155/2000/630301
Hepatitis C
Abstract
Hepatitis C has been identified as the most common cause of post-transfusion hepatitis worldwide, accounting for approximately 90% of this disease in Japan, the United States and Western Europe. Hepatitis C is a major global public health problem. New infections continue to occur, and the source of infection includes transfusion of blood or blood products from unscreened donors; transfusion of blood products that have not undergone viral inactivation; parenteral exposure to blood through use of contaminated and inadequately sterilized instruments and needles used in medical, dental and 'traditional' medicine; procedures such as hemodialysis; high risk sexual practices; household or sexual contacts of hepatitis C virus (HCV)-infected persons; and infants of HCV-infected mothers. In many countries, the relative contribution of the various sources of infection has not been defined with population-based epidemiological studies. Such studies are necessary to enable countries to prioritize their preventive measures and to make the most appropriate use of available resources. Given the substantial morbidity and mortality attributable to HCV-related chronic liver disease, each country, irrespective of economic status, should develop a plan of HCV-related public health activities for the prevention of new HCV infections and the treatment of established chronic infections.
Similar articles
-
Hepatitis C: public health strategies.J Hepatol. 1999;31 Suppl 1:146-51. doi: 10.1016/s0168-8278(99)80392-4. J Hepatol. 1999. PMID: 10622578 Review.
-
NIH Consensus Statement on Management of Hepatitis C: 2002.NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714 Review.
-
Current status of and strategies for hepatitis C control in South Korea.Clin Mol Hepatol. 2017 Sep;23(3):212-218. doi: 10.3350/cmh.2017.0105. Epub 2017 Sep 19. Clin Mol Hepatol. 2017. PMID: 28942625 Free PMC article. Review.
-
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.J Viral Hepat. 1999 Jan;6(1):35-47. J Viral Hepat. 1999. PMID: 10847128
-
Hepatitis C virus infection in dialysis patients.Hemodial Int. 2007 Jul;11(3):286-95. doi: 10.1111/j.1542-4758.2007.00181.x. Hemodial Int. 2007. PMID: 17576291 Review.
Cited by
-
Prevalence of hepatitis C virus antibody among undergraduates in ogbomoso, southwestern Nigeria.Afr J Infect Dis. 2014;8(2):40-3. doi: 10.4314/ajid.v8i2.5. Afr J Infect Dis. 2014. PMID: 25729536 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical